Clinical trial
Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
NCT02582515 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo
- Lead sponsor
- University of California, Los Angeles
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- August 31, 2017
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic tic disorder, tourette disorder